Latest On Fisher & Paykel Healthcare Corporation Limited (FSPKF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-12-05 05:00 EST | Dividend | A dividend of $0.03 has been announced on Nov 29, 2023. It will be paid Dec 18, 2023 with an ex-dividend date of Dec 5, 2023. | Neutral |  |
| 2023-06-26 06:00 EST | Dividend | A dividend of $0.32 has been announced on May 26, 2023. It will be paid Jul 7, 2023 with an ex-dividend date of Jun 26, 2023. | Neutral | |
| 2023-05-26 05:17 EST | News | Fisher & Paykel Healthcare Corporation Limited 2023 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-05-26 05:17 EST | News | Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2023 Earnings Call Transcript | N/A | |
| 2022-12-08 05:01 EST | Dividend | A dividend of $0.03 has been announced on Nov 29, 2022. It will be paid Dec 21, 2022 with an ex-dividend date of Dec 8, 2022. | Neutral | |
| 2022-11-28 22:32 EST | News | Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2023 Earnings Call Transcript | N/A | |
| 2022-11-28 22:32 EST | News | Fisher & Paykel Healthcare Corporation Limited 2023 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-06-22 05:59 EST | Dividend | A dividend of $0.04 has been announced on May 25, 2022. It will be paid Jul 6, 2022 with an ex-dividend date of Jun 22, 2022. | Neutral | |
| 2022-05-25 07:24 EST | News | Fisher & Paykel Healthcare Corporation Limited (FSPKF) CEO Lewis Gradon on Q4 2022 Results - Earnings Call Transcript | N/A | |
| 2021-12-02 05:02 EST | Dividend | A dividend of $0.19 has been announced on Nov 25, 2021. It will be paid Dec 15, 2021 with an ex-dividend date of Dec 2, 2021. | Neutral | |
| 2021-11-26 08:25 EST | News | Fisher & Paykel Healthcare Corporation Limited 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-11-26 08:25 EST | News | Fisher & Paykel Healthcare reports 1H results | N/A | |
| 2021-11-25 10:52 EST | News | Fisher & Paykel Healthcare Corporation Limited (FSPKF) CEO Lewis Gradon on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 13:27 EST | News | Fisher & Paykel Healthcare Corporation Limited (FSPKF) CEO Lewis Gradon on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 13:27 EST | News | Fisher & Paykel Healthcare Corporation Limited 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-06-24 06:03 EST | Dividend | A dividend of $0.31 has been announced on May 27, 2021. It will be paid Jul 7, 2021 with an ex-dividend date of Jun 24, 2021. | Neutral | |
| 2020-12-03 05:04 EST | Dividend | A dividend of $0.03 has been announced on Nov 25, 2020. It will be paid Dec 16, 2020 with an ex-dividend date of Dec 3, 2020. | Neutral | |
| 2020-11-26 23:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-25 12:32 EST | News | Fisher & Paykel Healthcare reports 1H results | N/A | |
| 2020-11-25 12:32 EST | News | Fisher & Paykel Healthcare Corporation Limited (FSPKF) CEO Lewis Gradon on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2020-11-25 12:32 EST | News | Fisher & Paykel Healthcare Corporation Limited 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-11-08 02:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 14:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-06 05:59 EST | Dividend | A dividend of $0.22 has been announced on Jun 29, 2020. It will be paid Jul 17, 2020 with an ex-dividend date of Jul 6, 2020. | Neutral | |
| 2020-07-02 22:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-30 16:38 EST | News | Fisher & Paykel Healthcare Corporation Limited (FSPKF) CEO Lewis Gradon on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2020-06-29 11:23 EST | News | Fisher & Paykel Healthcare reports FY results | N/A | |
| 2020-06-19 14:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 22:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-07 06:25 EST | Financials | Company financials have been released. | Neutral | |
About Fisher & Paykel Healthcare Corporation Limited (FSPKF):
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It provides its products for use in respiratory care, acute care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers myAIRVO 2, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
General
- Name Fisher & Paykel Healthcare Corporation Limited
- Symbol FSPKF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 4,710
- Fiscal Year EndMarch
- Web URLhttp://www.fphcare.com
View More
Valuation
- Trailing PE 91.65
- Forward PE 51.02
- Price/Sales (Trailing 12 Mt.) 11.9
- Price/Book (Most Recent Quarter) 15.59
- Enterprise Value Revenue 8.46
- Enterprise Value EBITDA 25.79
View More
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin 24%
- Return on Assets 23%
- Return on Equity 37%
- Earnings Per Share $0.25
- Revenue Per Share $0
- Gross Profit 835.8 million
- Quarterly Earnings Growth 59.4%
View More
Highlights
- Market Capitalization 12.99 billion
- PEG Ratio 4.5
- Book Value Per Share $0.93
View More
Share Statistics
- Shares Outstanding 576.36 million
- Shares Float 572.91 million
- % Held by Insiders 36%
- % Held by Institutions 33.57%
View More
Technicals
- Beta -0.13
- 52 Week High $25.94
- 52 Week Low $15.15
- 50 Day Moving Average 22.87
- 200 Day Moving Average 23.17
View More
Dividends
- Forward Annual Dividend Rate $0.21
- Forward Annual Dividend Yield 0.96%
- Payout Ratio 132%
- Dividend Date N/A
- ExDividend Date 2020-12-03
- Dividend Per Share $0.15
- Dividend Yield 0%
View More
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Dividend Calendar:
Fisher & Paykel Healthcare Corporation Limited pays out 132% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-06-30 | 2020-09-30 | $N/A | $0.13 | $0.00 | |
| 2020-03-31 | 2020-06-30 | $N/A | $0.13 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $N/A | $0.09 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $285.45 million | $0.10 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $285.45 million | $0.07 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $279.55 million | $0.07 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $279.55 million | $0.07 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $255.65 million | $0.06 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $255.65 million | $0.06 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $261.2 million | $0.06 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $261.2 million | $0.07 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $28.05 million | $0.07 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $27.19 million | $0.05 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $234.61 million | $0.05 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $234.61 million | $0.06 | $0.00 | |
| 2016-09-30 | 2016-12-31 | $0.06 | $0.00 | ||
| 2016-06-30 | 2016-09-30 | $0.05 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $0.05 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | $0.05 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $0.05 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $0.03 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | $0.04 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | $0.04 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $0.04 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.03 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.04 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.04 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.04 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.03 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.03 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.03 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.03 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.02 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.02 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.03 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.03 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.02 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.02 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.03 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.03 | $0.00 |
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | 27 million |
| Income Before Tax | N/A | N/A | N/A | N/A | 79.85 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 81.45 million |
| Gross Profit | N/A | N/A | N/A | N/A | 191.45 million |
| Ebit | N/A | N/A | N/A | N/A | 83 million |
| Operating Income | N/A | N/A | N/A | N/A | 83 million |
| Income Tax Expense | 43.75 million | 43.75 million | 22.35 million | 22.35 million | 19.25 million |
| Total Revenue | N/A | N/A | N/A | N/A | 285.45 million |
| Cost of Revenue | N/A | N/A | N/A | N/A | 94 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -3.15 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 60.6 million |
| Net Income Applicable to Common Shares | 112.75 million | 112.75 million | 83.05 million | 83.05 million | 60.6 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | 23.75 million |
| Change to Liabilities | 19.15 million | 19.15 million | 24.2 million | 24.2 million | -750000 |
| Total Cash Flow from Investing Activities | -40.95 million | -40.95 million | -58.3 million | -58.3 million | -19.55 million |
| Net Borrowings | -2.65 million | -2.65 million | -5.3 million | -5.3 million | -2.15 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | -40.3 million |
| Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
| Change in Cash | N/A | N/A | N/A | N/A | -3.3 million |
| Total Cash from Operating Activities | 109.05 million | 109.05 million | 103.95 million | 103.95 million | 56.75 million |
| Depreciation | N/A | N/A | N/A | N/A | 14.25 million |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | -5.1 million |
| Change to Account Receivables | N/A | N/A | N/A | N/A | -3.7 million |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 9.25 million | 9.25 million | 4.05 million | 4.05 million | -3.35 million |
| Capital Expenditures | N/A | N/A | N/A | N/A | 36.7 million |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 461.2 million | N/A | 336.3 million |
| Total Stockholder Equity | N/A | N/A | 973.8 million | N/A | 918.7 million |
| Other Current Liabilities | 69.6 million | 69.6 million | N/A | N/A | 36.9 million |
| Total Assets | N/A | N/A | 1.44 billion | N/A | 1.26 billion |
| Common Stock | 244.8 million | 244.8 million | 225.4 million | 225.4 million | 223.2 million |
| Other Current Assets | 11.5 million | 11.5 million | N/A | N/A | 9.9 million |
| Retained Earnings | 822.7 million | 822.7 million | 686.3 million | 686.3 million | 589.5 million |
| Other Liabilities | 32.5 million | 32.5 million | 81 million | 81 million | 37.9 million |
| Other Assets | 132.7 million | 132.7 million | 107.1 million | 107.1 million | 81.9 million |
| Cash | N/A | N/A | 67.1 million | N/A | 48.4 million |
| Total Current Liabilities | 336.1 million | 336.1 million | 334.6 million | N/A | 199.6 million |
| Other Stockholder Equity | 155.6 million | 155.6 million | 62.1 million | 62.1 million | 107.8 million |
| Property, Plant & Equipment | 777 million | 777 million | 735.3 million | 735.3 million | 690.8 million |
| Total Current Assets | 643.1 million | 643.1 million | 518.7 million | N/A | 412 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 1.14 billion | 1.14 billion | 899.9 million | 899.9 million | 848.4 million |
| Short Term Investments | N/A | N/A | 77.7 million | N/A | 45.2 million |
| Long Term Debt | N/A | N/A | 22 million | N/A | 74.7 million |
| Inventory | 233.6 million | 233.6 million | 146.5 million | N/A | 146.3 million |
| Accounts Payable | 196.7 million | 196.7 million | 69.3 million | N/A | 127.8 million |
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Chart:
Fisher & Paykel Healthcare Corporation Limited (FSPKF) News:
Below you will find a list of latest news for Fisher & Paykel Healthcare Corporation Limited (FSPKF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Fisher & Paykel Healthcare Corporation Limited (FSPKF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2001-09-20 | 8-A12G | Registration of securities [Section 12(g)] | https://www.sec.gov/Archives/edgar/data/1144690/000095012301506493/0000950123-01-506493-index.htm |
| 2001-10-23 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1144690/000095012301507465/0000950123-01-507465-index.htm |
| 2001-10-25 | 8-A12G/A | Registration of securities [Section 12(g)] | https://www.sec.gov/Archives/edgar/data/1144690/000095012301507553/0000950123-01-507553-index.htm |
| 2001-11-02 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1144690/000095012301507780/0000950123-01-507780-index.htm |
| 2001-11-09 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1144690/000095012301508129/0000950123-01-508129-index.htm |
| 2001-11-13 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1144690/000095012301508339/0000950123-01-508339-index.htm |
| 2002-02-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1144690/000095012302001464/0000950123-02-001464-index.htm |
| 2002-05-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1144690/000095012302005759/0000950123-02-005759-index.htm |
| 2002-07-01 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1144690/000095012302006687/0000950123-02-006687-index.htm |
| 2002-07-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1144690/000095012302006737/0000950123-02-006737-index.htm |
| 2002-08-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1144690/000095012302007573/0000950123-02-007573-index.htm |
| 2002-08-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1144690/000095012302008529/0000950123-02-008529-index.htm |
| 2002-08-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1144690/000095012302008581/0000950123-02-008581-index.htm |
| 2002-11-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1144690/000095012302010283/0000950123-02-010283-index.htm |
| 2002-12-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1144690/000095012302011569/0000950123-02-011569-index.htm |
| 2003-02-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1144690/000095012303001430/0000950123-03-001430-index.htm |
| 2003-02-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1144690/000095012303001431/0000950123-03-001431-index.htm |
| 2003-02-28 | 15-12G | Securities registration termination [Section 12(g)] | https://www.sec.gov/Archives/edgar/data/1144690/000095012303002180/0000950123-03-002180-index.htm |
| 2008-10-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1144690/000101915508000633/0001019155-08-000633-index.htm |
| 2001-09-13 | F-1 | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1144690/000109581101504884/0001095811-01-504884-index.htm |
| 2009-03-06 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1144690/000119380509000550/0001193805-09-000550-index.htm |